Comprehensive end-to-end services enable effective, streamlined communication with key stakeholders across all stages of drug development and commercializationBOSTON, March 21, 2018 - PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today introduced PAREXEL's Medical Writing Solutions, a newly integrated, end-to-end offering that provides a wide variety of communication services needed throughout each critical stage of the drug development and commercialization process.Biopharmaceutical companies today are increasingly in need of high quality documentation to meet...
Source: RealWire
- View Press Release
|
|
|
